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The contribution of mammary epithelial cells (MEC) to human immunodeficiency virus type 1 (HIV-1) in
breast milk remains largely unknown. While breast milk contains CD4 cells throughout the breast-feeding
period, it is not known whether MEC directly support HIV-1 infection or facilitate infection of CD4 cells in
the breast compartment. This study evaluated primary human MEC for direct infection with HIV-1 and for
indirect transfer of infection to CD4 target cells. Primary human MEC were isolated and assessed for
expression of HIV-1 receptors. MEC were exposed to CCR5-, CXCR4- and dual-tropic strains of HIV-1 and
evaluated for viral reverse transcription and integration and productive viral infection. MEC were also tested
for the ability to transfer HIV to CD4 target cells and to activate resting CD4 T cells. Our results
demonstrate that MEC express HIV-1 receptor proteins CD4, CCR5, CXCR4, and galactosyl ceramide
(GalCer). While no evidence for direct infection of MEC was found, HIV-1 virions were observed in MEC endosomal
compartments. Coculture of HIV-exposed MEC resulted in productive infection of activated CD4 T cells. In
addition, MEC secretions increased HIV-1 replication and proliferation of infected target cells. Overall, our
results indicate that MEC are capable of endosomal uptake of HIV-1 and can facilitate virus infection and
replication in CD4 target cells. These findings suggest that MEC may serve as a viral reservoir for HIV-1 and
may enhance infection of CD4 T lymphocytes in vivo.
In the more than 2 decades since the discovery of human
immunodeficiency virus (HIV) transmission via breast milk,
little progress has been made in understanding the contribu-
tion made by the mammary gland to HIV replication in mam-
mary tissue and breast milk. Mammary epithelial cells (MEC),
the milk-secreting cells of the mammary gland, play a unique
functional role within breast tissue. While most epithelial lay-
ers in the body serve a protective function, MEC selectively
take up components of the plasma and manufacture constitu-
ents of breast milk to secrete a nutrient- and immune factor-
rich fluid (22).
In a nonpregnant or nonlactating woman, the mammary
gland contains a slowly dividing population of mammary epi-
thelial cell progenitors, known as mammary stem cells, which
are present in the breast tissue from birth and persist through-
out most of a woman’s premenopausal life (14). Hormonal
changes associated with pregnancy and lactation induce rapid
proliferation and terminal differentiation of these cells into
mammary epithelial secretory alveolar cells, epithelial ductal
cells, or myoepithelial cells (14, 25, 34, 39, 43). Stem cell
division is primarily asymmetric, such that one daughter cell
differentiates while the other retains the stem cell phenotype
(11, 13, 43). Due to the steep rise in prolactin in the first half
of pregnancy, hormone-induced proliferation and differentia-
tion of mammary stem cells are largely complete by the second
trimester (25). Whether mammary stem cells or their differen-
tiated progeny are susceptible to human immunodeficiency
virus type 1 (HIV-1) infection or sequestration of virions in
endosomal compartments is largely unknown.
Milk is a very cellular fluid throughout the lactation period,
with more than 106 leukocytes/ml in the colostrum (5, 26),
followed by a decline over time to approximately 105 to 104
leukocytes/ml in mature milk (9, 15, 16, 26). To reach the milk,
lymphocytes and monocyte/macrophage populations must traf-
fic paracellularly or transcellularly through a normally imper-
meable MEC monolayer on their way into the milk duct. Ep-
idemiologic studies show that HIV-1 RNA and proviral DNA
in breast milk are significantly associated with virus transmis-
sion (19, 28–30); however, little is known about the interaction
between MEC and leukocytes in the mammary glands of HIV-
infected women. Limited attention has been paid to the con-
cept that MEC may contribute to the HIV-1 viral load in breast
milk. This may be due, in part, to an early study of primary
human MEC using a laboratory-adapted strain of HIV-1,
which demonstrated low levels of viral replication in the MEC
(40). However, even low-level HIV-1 replication or transcyto-
sis of virions across MEC without direct infection could signif-
icantly impact the persistence and spread of virus within the
mammary gland. MEC and leukocytes entering breast milk
share close physical contact. Therefore, cell-to-cell contact be-
tween MEC, which either harbor HIV-1 or bind and transmit
the virus to susceptible target cells in transit to the milk, and
leukocytes could provide a potential mechanism for seeding
newly infected cells into the breast milk.
There is growing evidence that the mammary gland contrib-
utes to breast milk transmission of HIV-1 beyond simply al-
lowing the passive flow of HIV-1 virions and infected cells into
the milk. Treatment of HIV-1-infected pregnant and lactating
women with highly active antiretroviral therapy (HAART) has
been shown to decrease breast milk cell-free HIV-1 RNA but
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not cell-associated HIV-1 DNA (23, 36). In addition, phyloge-
netic analyses of HIV-1 DNA sequences derived from paired
plasma and breast milk of HIV-positive African women show
genetic differences between HIV-1 from blood and that from
breast milk (4, 36). A recent study of lactating rhesus monkeys
chronically infected with simian immunodeficiency virus (SIV)
demonstrated the presence of phylogenetically similar or iden-
tical groups of SIV variants in the milk, suggesting local rep-
lication of virus within the mammary gland (27).
The mechanism(s) of HIV-1 infection, replication, and dis-
semination in human mammary tissue is unknown. We under-
took the present study to examine basic mechanistic questions,
including characterization of primary human MEC for expres-
sion of HIV-1 receptors, coreceptors, and alternate receptors;
evaluation of the susceptibility of MEC to direct infection with
HIV-1; and investigation of indirect modes whereby MEC
might facilitate HIV-1 infection of target cells. Our results
indicate that, while MEC do not support integration of HIV-1,
they do sequester and release infectious virions, facilitating
infection of CD4 cells. In addition, secretions from the apical
(luminal) surface of MEC increase HIV-1 replication and pro-
liferation of HIV-infected cells.
MATERIALS AND METHODS
Subjects. Breast tissue was obtained from patients undergoing breast reduc-
tion surgery, following informed consent. Patients who were eligible to donate
tissue to this study included premenopausal women of 40 years of age sched-
uled for bilateral mammoplasty, with no personal history of breast cancer and no
prior abnormal mammogram or breast biopsy.
As the standard of care, the pathology department at the Dartmouth-Hitch-
cock Medical Center (DHMC) requires that all breast tissue samples removed at
surgery be tested for occult neoplasia. This process requires up to 24 h, neces-
sitating the immediate placement of study tissue into fresh medium (Dulbecco’s
modified Eagle’s medium [DMEM]–F-12 medium with 10% fetal bovine serum
[FBS], antibiotics, and amphotericin B) and storage at 4°C until release by the
pathologist. In addition, to maintain the DHMC standard of care for mammo-
plasty patients, only women who had 500 g of tissue removed per breast were
eligible to donate tissue to the study.
The protocol for obtaining tissue for this study was approved by the Dart-
mouth College Committee for the Protection of Human Subjects.
Dissociation of human mammary tissue and enrichment for BerEp4 cells.
Methods for dissociation of tissue and enrichment for BerEp4 cells were
adapted from published protocols for isolation and enrichment of MEC from
human breast tissue (10, 13, 38). In brief, human mammary tissue was minced
and placed into dissociation beakers (Bellco Glass, Vineland, NJ) with digestive
medium containing DMEM–F-12 medium, bovine serum albumin (BSA), colla-
genase, hyaluronidase, insulin, hydrocortisone, and ampicillin, streptomycin, and
amphotericin B and shaken at 70 rpm in a 37°C incubator at 5% CO2 overnight.
The following day, the mixture was filtered through a 250-m wire mesh, and the
undigested tissue was placed into fresh digestion medium for an additional 6 to
8 h. The filtrate was centrifuged at 80  g for 4 min until the supernatant was
clear. To aid in removal of fibroblasts in the remaining supernatant, Accumax
(Innovative Cell Technologies, Inc., San Diego, CA), an enzymatic reagent used
to disaggregate cell clusters, was added in a 1:1 volume ratio with the remaining
cell pellet and medium after the last wash, and the solution was mixed by
pipetting, incubated at 37°C for 7 min, and pipetted multiple times to separate
the remaining fibroblasts from the MEC. Cells were washed with phosphate-
buffered saline (PBS) containing 0.1% BSA-0.6% sodium nitrate at 80  g for 4
min until the supernatant was clear, followed by a last wash at 600  g for 10 min.
The cell pellet was resuspended in PBS-BSA-sodium nitrate solution, and en-
richment for BerEp4 cells was performed using immunomagnetic beads coated
with anti-BerEP4 (EpCAM) monoclonal antibody (MAb) (CELLection epithe-
lial enrich dynabeads; Invitrogen, Carlsbad, CA). Enriched MEC were either
immediately placed into culture with mammary epithelial growth medium
(MEGM) (Lonza, Rockland, ME) or suspended in 90% FBS-10% dimethyl
sulfoxide (DMSO) and stored in liquid nitrogen for future use.
The purity of BerEp4 cells was assessed by staining enriched cell cultures for
BerEp4 and the panleukocyte marker CD45. Enriched MEC were cultured on
glass coverslips (Fisherbrand, Pittsburgh, PA) in MEGM until reaching a mini-
mum of 70 to 80% confluence. Cells were washed with PBS, fixed with 4%
methanol-free paraformaldehyde (PF) for 10 min at room temperature (RT),
and washed once with PBS, followed by three PBS rinses of 5 min each. Cells
were then blocked with 1% BSA-1% FBS in PBS for 30 min at RT. After
aspiration of the blocking solution, purified mouse anti-human BerEp4 IgG1
(Dako, Carpinteria, CA) and mouse anti-human CD45 IgG1 conjugated to Alexa
Fluor 405 (Invitrogen, Carlsbad, CA) were added to designated coverslips at a
concentration of 10 g/ml in blocking solution and incubated for 1 h at RT. Cells
were washed five times with 0.1% BSA in PBS. Goat F(ab)2 anti-mouse IgG–
fluorescein isothiocyanate (FITC) secondary antibody (R&D Systems, Minne-
apolis, MN) was added to cells stained for BerEp4, and cells were incubated for
1 h at RT in the dark. Cells were washed five times with 0.1% BSA in PBS,
followed by three washes in PBS for 15 min each, and incubated for 5 min at RT
with 4% methanol-free paraformaldehyde, followed by three washes with PBS.
After being air dried, the coverslips were mounted onto glass microscope slides
with Prolong Gold antifade reagent (Invitrogen). The mammary epithelial cell
line MCF-10A was used as a positive control for BerEp4 staining, and peripheral
blood mononuclear cell (PBMC)-derived macrophages were utilized as a positive
control for CD45 staining. Slides were imaged using a Bio-Rad MR1000 confocal
scanning laser microscope system equipped with a krypton/argon laser and a 40
oil immersion objective (Hercules, CA). Images were captured using Zeiss LSM
Image software. Simultaneous imaging took place using differential interference
contrast (DIC) for visualizing cell morphology to assess whether fibroblasts were
present.
Detection of HIV-1 receptors CD4, CXCR4, CCR5, and GalCer. Enriched
MEC were cultured on glass coverslips (Fisherbrand) in MEGM until reaching
a minimum of 50% confluence. Cells were washed with PBS, fixed with 4%
methanol-free paraformaldehyde for 10 min at RT, and washed once with PBS,
followed by three PBS rinses of 5 min each. Cells were then blocked with 1%
BSA-1% FBS in PBS for 30 min at RT. After aspiration of the blocking solution,
purified primary antibodies mouse anti-human CD4 IgG1 (BD Pharmingen, San
Jose, CA), mouse anti-human CD184 (CXCR4) IgG2a() (BD Pharmingen),
mouse anti-human CD195 (CCR5) IgG2a() (BD Pharmingen), and mouse
anti-human galactocerebroside MAb IgG3 (Millipore, Billerica, MA) were
added to designated coverslips at a concentration of 10 g/ml in blocking solu-
tion, and the mixtures were incubated for 1 h at RT. Cells were washed five times
with 0.1% BSA in PBS, goat F(ab)2 anti-mouse IgG–FITC (R&D Systems)
secondary antibody was added, and cells were incubated for 1 h at RT in the
dark. Cells were washed five times with 0.1% BSA in PBS, followed by three
washes in PBS for 15 min each, and incubated for 5 min at RT with 4%
methanol-free paraformaldehyde, followed by three washes with PBS. After
being air dried, the coverslips were mounted onto glass microscope slides with
Prolong Gold antifade reagent with DAPI (4,6-diamidino-2-phenylindole) (In-
vitrogen). TZM-bl cells were used as a positive control for expression of CD4,
CXCR4, and CCR5. HT-29 cells served as a positive control for galactosyl
ceramide (GalCer) expression. FITC-conjugated mouse isotype controls (In-
vitrogen) were also used in all staining experiments. Slides were imaged using a
Bio-Rad MR1000 confocal scanning laser microscope system equipped with a
krypton/argon laser and a 40 oil immersion objective (Hercules, CA). Images
were captured using Zeiss LSM Image software.
Detection of CD4 mRNA. Detection of CD4 mRNA was quantified by real-
time PCR with a commercially available kit (TaqMan Gene Expression Cells-
to-CT kit; Applied Biosystems, Austin, TX) using the CD4 expression assay
(Applied Biosystems), and the human beta-actin gene expression assay (Applied
Biosystems) was used as a positive control. All key reagents and protocols for
PCR cycling were followed per the manufacturer’s instructions. Samples were
amplified on an ABI Prism 7000 sequence detection system and data collected on
Applied Biosystems 7000 sequence detection software.
PCR and p24 ELISA. Enriched MEC were cultured in 48-well plates until
reaching at least 80% confluence. CCR5-tropic HIV-1BaL, CXCR4-tropic
HIV-1HC4, and dual-tropic HIV-1C7/86 strains were grown and DNase treated, titers
in PBMCs were determined, and strains were added at 300 50% tissue culture
infective doses (TCID50) to wells in 200 l of medium and incubated for 2 h at
37°C. Wells were washed three times, and the MEC were incubated for 14 days
at 37°C. Phytohemagglutinin (PHA)-activated HIV-infected and uninfected
PBMCs were used as controls. Wells were replenished with fresh medium on days 4,
7, 10, and 14. Supernatants were collected on days 0, 7, and 14 and measured for
HIV p24 antigen by use of a commercially available enzyme-linked immunosor-
bent assay (ELISA) (Perkin Elmer, Waltham, MA) that has a limit of sensitivity
of 4.3 pg/ml. Total genomic cellular DNA was extracted from MEC on day 14 by
use of a Qiagen blood minikit (Qiagen, Valencia, CA). Reverse transcription and
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integration of HIV-1 proviral DNA were assessed by PCR. PCR for reverse
transcription was performed using the long terminal repeat (LTR) sense primer
M667 (5-GGCTAACTAGGGAACCCACTG-3) (Integrated DNA Technolo-
gies [IDT], Coralville, IA) and the antisense primer AA55 (5-CTGCTAGAG
ATTTTCCACACTGAC-3) (IDT). The first round of the HIV-1 integration
PCR was performed by using the Alu sense primer (5-GCCTCCCAAAGTGC
TGGGATTA-3) (IDT), which binds to short DNA sequences occurring in
multiple locations throughout the human genome, and the HIV-1 Gag antisense
primer (5-CCTGCGTCGAGAGAGCTCCTCTGG-3) (IDT) (3). Five micro-
liters of first-round product was then used in nested PCR, with the LTR sense
primer M667 (IDT) and the antisense primer AA55 (IDT) (3). Products from the
second-round PCR were run on 1% agarose gels with ethidium bromide to detect
an expected 140-bp fragment. HIV-exposed and washed PBMCs were used as
positive controls, and HIV-unexposed MEC and PBMCs were used as negative
controls. PCR for actin was performed using a human beta-actin gene sense
primer (5-CACTCTTCCAGCCTTCCTTCC-3) and antisense primer (5-CTG
TGTTGGCGTACAGGTCT-3). Experiments were performed in triplicate un-
der each condition.
GFP reporter virus. MEC were cultured on glass coverslips in 24-well plates in
MEGM until reaching a minimum of 50% confluence. Fifty microliters of
NLENG1i_BaL.ecto, a green fluorescent protein (GFP) reporter virus designed
to fluoresce within a cell after HIV-1 integration into the genome (provided
courtesy of John Kappes and Christina Ochsenbauer-Jambor, University of Al-
abama, Birmingham), was added to MEC in 200 l of medium, and the mixture
was incubated for 2 h, followed by addition of 2 ml of medium. HIV-exposed and
-unexposed TZM-bl cells were used as controls, as were HIV-unexposed MEC.
Cultures were examined after 48 h and again after 5 days under bright-field light
microscopy and GFP-filtered microscopy, utilizing an inverted Olympus IX50
microscope system with a mercury bulb and a GFP filter, attached to an Olympus
digital camera, and QCapturePro imaging software.
Electron microscopy. MEC were cultured on 6-well culture plates until reach-
ing at least 80% confluence. Test wells were exposed to either a minimum of 200
l cell-free HIV-1BaL or HIV-1HC4 or a minimum of 8  106 PHA-activated
PBMCs preinfected for 48 h with the same viral strains. Unexposed MEC and
PBMCs were used as controls. MEC exposure to cell-free HIV-1 ranged from
0.5 h to 7 days, and MEC exposure to infected PBMCs ranged from 2 to 7 days.
Cells were washed 3 times with PBS and fixed in 2% glutaraldehyde (GTA)-1%
paraformaldehyde (PF) in 0.1 M Na-cacodylate buffer at RT. After 15 min,
solutions were gently replaced with fresh fixative. After 1 h, a cell scraper was
used to lift the cell monolayer, which was transferred to 15-ml tubes. The cells
were gently centrifuged, and fresh fixative was added. After an additional hour of
fixation, the samples were stored overnight at 4°C. Samples were washed three
times for 15 min each in 0.1 M Na-cacodylate–0.15 M sucrose buffer, postfixed
with 1% OsO4 in 0.1 M Na-cacodylate–0.15 M sucrose buffer for 2 h at RT, and
en bloc stained in 2% aqueous uranyl acetate. Cells were dehydrated through a
graded series of ethanols and propylene oxide and embedded in Epon (LX112
kit; Ladd, Inc., Williston, VT). Thin sections were mounted on 400HH Cu grids
(Electron Microscopy Sciences, Hatfield, PA), stained with methanolic uranyl
acetate for 15 min and Reynold’s lead citrate for 3 min. All images were taken
at 100 kV on a JEOL 1010 transmission electron microscope equipped with an
XR-41B AMT digital camera.
Coculture of CD4 T lymphocytes with HIV-1-exposed MEC. MEC were
seeded into 48-well plates and cultured until reaching at least 80% confluence.
HIV-1BaL (300 TCID50) was added to designated wells in 200 l medium and
incubated for 2 h at 37°C. Wells were washed three times, and supernatant was
collected after the last wash (day 0) and stored at 70°C. Two million PHA-
activated or nonactivated CD4 T lymphocytes were negatively selected from
PBMCs by use of EasySep CD4 T Cell Enrichment immunomagnetic beads
(Stem Cell Technologies, Vancouver, BC, Canada). The enriched CD4 T cells
were added to each test well immediately after day 0 supernatant collection.
Supernatants were collected and wells replenished with fresh medium at days 4,
7, 10, and 14. HIV-exposed PBMCs and -unexposed MEC and PBMCs were used
as positive and negative controls, respectively. Samples were evaluated for HIV-1
p24 antigen by use of a commercially available ELISA (Perkin Elmer). Cell
viability of PHA-activated and nonactivated CD4 T lymphocytes in culture was
measured at the end of the experiment (day 30) by using CellTiter Aqueous One
solution (Promega, Madison, WI). Experiments were performed in triplicate
under each condition.
Activation of GFP-labeled Jurkat cells latently infected with HIV-1. MEC
were seeded at 80,000 cells/0.4-m transwell insert (BD, Franklin Lakes, NJ) and
cultured until a tightly polarized monolayer was achieved, as determined by a
transwell epithelial resistance (TER) of 1,000 	 measured using an epithelial
voltohmmeter (EVOM; World Precision Instruments, Sarasota, FL). After 48 h,
apical- and basolateral-surface conditioned media were removed and placed in
separate wells. J-Lat Tat-GFP clone 82 Jurkat cells (kindly contributed to the
NIH AIDS Research and Reference Reagent Program by Eric Verdin), a Jurkat
cell GFP reporter model for latent HIV infection that increases in fluorescence
intensity if activated, were added to the cell-free MEC conditioned supernatants
(1  106/well) and allowed to incubate overnight at 37°C. In parallel experiments,
MEC were seeded in 48-well plates and cultured until reaching at least 80%
confluence. J-Lat Tat-GFP clone 82 Jurkat cells (1  106/well) were added to
evaluate the effect of direct contact with MEC on fluorescence intensity after
overnight incubation at 37°C. J-Lat Tat-GFP cells cultured overnight in fresh
medium alone served as negative controls, while those cultured in medium with
10 ng/ml human recombinant tumor necrosis factor alpha (TNF-
) (Sigma, St.
Louis, MO) served as positive controls. Wild-type (WT) Jurkat cells were used to
measure cellular autofluorescence. Cells were washed in PBS and fixed in 1%
paraformaldehyde. GFP fluorescence was measured using a FACScan flow cy-
tometer (Becton Dickinson, San Jose, CA). A gate (R1) was drawn to include
live cells; from the live-cell population, gate R2 was drawn to exclude autofluo-
rescence exhibited by WT Jurkat cells (18). Data comparing mean fluorescence
intensities among the test and control conditions were obtained utilizing infor-
mation from gate R2.
Effects of MEC conditioned medium on PBMC proliferation and HIV-1 rep-
lication in infected PBMCs. MEC were cultured in MEGM on 0.4-m transwell
inserts (BD) placed in 24-well plates until a minimum TER of 1,000 	 was
reached. Conditioned medium from the apical compartment was collected and
replaced with fresh medium every 48 to 72 h and stored at 20°C. PHA-activated
PBMCs were infected with HIV-1BaL (300 TCID50/well) and cultured with MEC
apical-surface conditioned medium for 7 days. HIV-infected PBMCs cultured in
normal medium were used as controls. The cultures were tested for HIV-1 p24
antigen by ELISA (Perkin Elmer) and for cell viability/proliferation by use of
CellTiter Aqueous One reagent (Promega) at day 7.
Measurement of cytokines and chemokines from apical surfaces of MEC.
MEC were cultured in MEGM on 0.4-m transwell inserts placed in 24-well
plates until a minimum TER of 1,000 	 was reached. Conditioned medium from
the apical compartment was collected every 48 to 72 h, and results were assessed
against a panel of 27 human cytokines, chemokines, and growth factors by
utilizing a multiplex human Luminex assay (Bio-Rad). Because interleukin-8
(IL-8) concentrations were beyond the upper level of detection of the Luminex
assay, conditioned medium was measured again using an IL-8 ELISA kit (Bio-
Legend, San Diego, CA).
Statistical analysis. SPSS version 11.5 (Chicago, IL) was used to calculate
statistical significance (two-tailed P value), with Student’s t test for comparison.
RESULTS
Study subjects. MEC from adult subjects of 40 years of age
consenting to breast reduction were utilized for this study.
Eligible subjects had no history of mammary neoplasia, and
clinical and microscopic examination of the tissue indicated no
pathology associated with the donated tissue. No association
between subject age and number of MEC enriched from mam-
mary tissue was observed.
MEC isolation yields a highly pure population. In the non-
lactating mammary gland, MEC are the minority cell type amid
adipocytes and connective tissue (21). By use of methods adapted
from established protocols (10, 13, 38), 2  106 to 10  106 MEC
were reliably obtained from approximately 100 g of tissue,
depending on the patient sample. In order to preserve live cells
for use in subsequent experiments, we chose to use confocal
microscopy rather than flow cytometry for confirmation of
MEC purity. After optimization of the isolation protocol, en-
riched MEC were cultured on glass coverslips. After 7 to 10
days in culture (70 to 80% cell confluence), MEC were stained
for expression of the epithelial cell marker BerEp4, as well as
the leukocyte marker CD45. Differential interference contrast
(DIC) was carried out using Zeiss LSM software to simulta-
neously view cells in grayscale in order to confirm the mor-
phology of MEC. Visualization of the entire coverslip using the
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10 objective, followed by that of a minimum of 20 fields per
coverslip using the 40 objective, resulted in observation of
only BerEp4 cells. Moreover, DIC visualization confirmed
the morphology of enriched cells as epithelial in nature.
MEC express HIV-1 receptors and coreceptors in the cyto-
plasm and nucleus. To identify whether MEC might be sus-
ceptible to direct infection with HIV, we first characterized
MEC for expression of HIV-1 receptors and coreceptors. En-
riched MEC were grown on glass coverslips, and the cells were
stained with antibodies specific for the HIV-1 receptors and
coreceptors CD4, CCR5, and CXCR4 and the alternate recep-
tor galactosyl ceramide (GalCer). Our results demonstrate that
MEC consistently express CCR5, CXCR4, and GalCer (Fig.
1). Z-stack imaging using confocal microscopy confirmed ex-
pression of these receptor proteins throughout the cytoplasm,
compared to staining only on the outer membrane of the con-
trol epithelial cell lines TZM-bl and HT-29. MEC from a
minimum of three subjects stained negative for CD4; however,
cells from one subject stained positive for CD4 expression,
with Z-stack imaging confirming the presence of CD4 protein
in the cell nucleus (Fig. 1G). Real-time PCR confirmed the
presence of mRNA for CD4 in MEC from three subjects
tested, suggesting that MEC are transcriptionally active for
CD4 mRNA expression (data not shown) but that protein
expression is restricted or absent. Taken together, these results
indicate that primary human MEC express HIV-1 coreceptors,
including CCR5, CXCR4, and GalCer, while expression of
CD4 on the cell surface is not detected.
MEC are not directly susceptible to infection with CCR5-
and CXCR4-tropic strains of HIV-1. An early study of pri-
mary MEC and immortalized mammary epithelial cell lines,
using HIV-1HTLV-IIIB cultured in chronically infected H9
cells and HIV-1P1, a highly cytopathic patient strain, cul-
tured in C8166 cells, reported low-level productive infection
of MEC (100 pg/ml of HIV p24 antigen) (40). However, the
use of laboratory-adapted and highly pathogenic strains of
HIV-1 may not be representative of physiologically relevant
conditions. We utilized CCR5-tropic HIV-1BaL, a strain known
to readily infect susceptible CD4 target cells, as well as two
primary patient isolates, CXCR4-tropic HIV-1HC4 and dual-
tropic HIV-1C7/86. In addition to the assessment of HIV-1 p24
antigen, HIV-1 infection of MEC was evaluated by PCR and
by using a green fluorescent protein (GFP)-labeled reporter
virus.
Figure 2 shows a representative PCR result for HIV-1 re-
verse transcription and integration in MEC and PBMCs. While
PBMCs support HIV-1 reverse transcription and viral integra-
tion with CCR5-, CXCR4-, and dual-tropic strains, there was
no evidence of the presence of HIV-1 reverse transcription or
integration in MEC with any of the HIV-1 isolates tested. In
addition, while PBMC controls demonstrated significant pro-
ductive HIV-1 infection with all three HIV-1 strains (200
ng/ml p24 by day 14), MEC cultures yielded no detectable
HIV-1 p24 antigen in culture supernatants under the same
conditions (data not shown).
To further substantiate our findings, we tested a recently
developed GFP reporter virus, NLENG1i_BaL.ecto (courtesy
of John Kappes and Christina Ochsenbauer-Jambor, Univer-
sity of Alabama, Birmingham). While TZM-bl cells exposed to
GFP–HIV-1BaL were positive for GFP fluorescence as ob-
served by microscopy at 48 h and 5 days after virus inoculation,
no evidence of GFP fluorescence was observed in MEC from
three subjects over the same time course (data not shown).
Taken together, our results provide evidence to indicate that
MEC are not directly susceptible to infection with CCR5-,
CXCR4-, and dual-tropic HIV-1 strains. Our findings do not
preclude the possibility of MEC infection as a rare event but
suggest that these cells are relatively refractory to HIV-1 entry,
reverse transcription, and integration through normal fu-
sion/entry pathways. Detection of CD4, CCR5, CXCR4, and
GalCer expression by MEC raises the possibility that HIV-1
may bind surface receptors on MEC and may be internalized
through alternate mechanisms.
Endocytosis of HIV-1 by MEC. Using electron microscopy
(EM), we investigated the possibility that HIV-1 entry into
MEC may occur through endocytosis. After MEC were cul-
tured with HIV-infected PBMCs in 6-well plates, cell layers
were fixed, removed, and prepared for EM. HIV-1 virions were
observed in membrane-coated vesicles inside MEC, suggesting
endocytic uptake of virions (Fig. 3). Interestingly, close contact
of MEC with lymphocytes was also observed, both by forma-
tion of junctions and clefts (Fig. 4A and B) and by total en-
gulfment of lymphocytes by MEC (Fig. 4C and D). In the latter
case, both cell types were healthy and intact, indicating that
lymphocytes were not being degraded by MEC. The formation
of cell-to-cell junctions and total engulfment suggest that lym-
phocytes and MEC communicate with one another via specific
cellular interactions.
MEC facilitate CD4 T-cell infection with HIV-1. The find-
ing that MEC can endocytose HIV-1 virions led to further
investigation of the ability of MEC to transfer virions to CD4
target cells. This process has previously been demonstrated in
nonepithelial cells, such as dendritic cells (DC) (45). As milk is
a cellular fluid, lymphocytes presumably come into close
contact with MEC as they travel from the underlying basolateral
tissue and circulate into the milk lumen. It is reasonable to as-
sume that endocytic uptake of HIV-1 by MEC might lead to
subsequent release of virions into the milk lumen or directly to
uninfected CD4 cells in close proximity.
To evaluate this possibility, MEC were exposed to HIV,
washed extensively to remove unbound virus, and cocultured
with uninfected, PHA-activated CD4 T lymphocytes. CD4
T cells consistently became HIV infected after coculture with
HIV-exposed and washed MEC (Fig. 5). Target cell infection
occurred even after trypsin treatment of HIV-exposed and
washed MEC (data not shown). These results indicate that
HIV capture by MEC and transfer of virions to nearby CD4
target cells constitute a possible mechanism by which unin-
fected CD4 T lymphocytes traversing the mammary epithe-
lium into breast milk may become HIV-1 infected.
MEC sustain but do not activate resting CD4 T cells. The
persistence of HIV-1 proviral DNA in breast milk of women
on HAART has led to speculation that a quiescent reservoir of
HIV-infected cells may home to the breast milk (23, 36). It is
not known whether MEC play a role in maintaining this res-
ervoir of HIV-infected resting cells within breast tissue. In
experiments carried out to evaluate this in vitro, HIV-exposed
and washed MEC were cocultured with resting CD4 T lym-
phocytes. After 10 days, the cocultures did not yield detectable
productive infection as measured by HIV p24 antigen in the
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FIG. 1. Primary human MEC express HIV-1 receptors, coreceptors, and an alternate receptor. Confocal microscopy images of MEC stained
for HIV receptors (left) and the same cells imaged by DIC (right). Nuclei are stained blue with DAPI. An immunomagnetic bead can be observed
in the DIC image shown in panel D. (A) GalCer expression (yellow). (C) CCR5 expression (green). (E) CXCR4 expression (red). (G) CD4
expression (pink). Z-stack imaging confirmed the presence of receptors within the cytoplasm and/or nucleus as shown. Similar results were obtained
in two additional subjects, with the exception of CD4 expression. CD4 mRNA was confirmed in three subjects by use of real-time PCR.
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culture supernatants (Fig. 5), nor was productive infection
detectable by p24 antigen ELISA after 4 weeks. After 30 days
of coculture with MEC, the resting cells were removed, and
their viability was assessed relative to that of resting CD4 T
cells cultured alone under the same conditions. Interestingly,
the viability of resting CD4 T cells cocultured with MEC
(optical density at 490 nm [OD490] of 0.446, 0.514, and 1.022 in
independent experiments) was on average 1.65-fold (range,
1.51- to 1.86-fold) greater than that of resting CD4 T cells
cultured alone for the same time period (OD490 of 0.292, 0.276,
and 0.644). The medium control OD490 in each experiment was
less than 0.175, suggesting that MEC may play a role in sus-
taining the resting T-cell population.
In further experiments, we tested whether MEC could acti-
vate T cells latently infected with HIV-1. J-Lat Tat-GFP clone
82 Jurkat cells (kindly contributed to the NIH AIDS Research
and Reference Reagent Program by Eric Verdin). These cells
were cocultured overnight directly with MEC and, in separate
experiments, were exposed to the apical or basolateral secre-
tions obtained from culturing MEC on transwell inserts. Our
flow cytometry results demonstrate no effect on cell activation
or GFP expression when cells latently infected with HIV were
exposed directly to MEC or to MEC conditioned medium,
while treatment of Jurkat-GFP cells with TNF-
 resulted in
high levels of GFP expression (data not shown).
Secretions from polarized MEC increase HIV replication
and proliferation of HIV-infected target cells. After observing
increased survival of resting CD4 T cells cocultured with MEC,
we further examined whether MEC might also affect HIV
replication in activated target cells. Culturing MEC on trans-
well inserts allows epithelial cells to form a tightly polarized
monolayer, more closely mimicking MEC growth in vivo.
The results of these experiments demonstrate a statistically
significant increase in viral replication in HIV-exposed PBMCs
when cells were cultured in the presence of conditioned me-
dium from the apical surface of polarized MEC compared to
that for cells cultured in medium alone (Fig. 6A). Proliferation
of PBMCs was also significantly greater when cells were cul-
tured in the MEC conditioned medium (Fig. 6B). One inter-
pretation of these findings is that increased viral replication is
directly associated with increased target cell proliferation.
These results indicate that MEC secretions from the apical
side of the cells facilitate target cell viability and proliferation
and HIV-1 replication.
FIG. 2. Primary human MEC do not support HIV reverse transcription or integration of the CCR5-, CXCR4-, or dual-tropic strains tested.
PCR results for HIV-1 reverse transcription and integration of CCR5-tropic HIV-1BaL, CXCR4-tropic HIV-1HC4, and dual-tropic HIV-1C7/86 in
both primary human MEC and PBMC controls. The bottom row shows PCR results for human beta-actin genomic DNA. Lanes 1 to 4, MEC; lanes
5 to 8, PBMCs; lane 9, negative control (no DNA). Experiments were performed in triplicate under each condition. Similar results were obtained
with MEC from three additional subjects.
FIG. 3. MEC endocytose HIV-1 virions from infected PBMCs. Transmission electron microscopy images showing HIV-1 virions inside MEC
endocytic compartments, with panels from left to right exhibiting progressive enlargement of the boxed area. The image shows HIV-1HC4 virions.
Experiments were performed in duplicate with both CCR5-tropic HIV-1BaL and CXCR4-tropic HIV-1HC4. Similar experiments were repeated with
MEC from two additional subjects. L, lymphocyte.
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Analysis of Luminex and ELISA data from MEC secretions
(Fig. 6C) (mean concentrations of 10 pg/ml) revealed that
MEC are highly secretory cells that release a variety of im-
mune mediators with widely ranging concentrations. Several of
these factors, including IL-8 and IL-6, have been shown to
upregulate HIV-1 replication in vitro (7, 12, 20) and may con-
tribute to the observed increase in virus replication in PBMCs
exposed to MEC secretions.
DISCUSSION
This is the first study to demonstrate endocytosis of HIV-1
virions by primary human MEC. In addition, HIV-exposed
MEC facilitate infection of activated target cells, presumably
by release of previously endocytosed HIV virions. Moreover,
MEC appear to form intimate junctions with lymphocytes and
in some cases completely engulf intact lymphocytes, suggesting
close cell-to-cell communication between MEC and lympho-
cytes. Furthermore, MEC secretions from the apical surface
significantly increase cell proliferation and HIV-1 replication
in infected target cells.
In contrast to findings from an early study by Toniolo et al.
(40), we did not find evidence to suggest that MEC are sus-
ceptible to direct infection by HIV-1, based on PCR evaluation
of HIV-1 reverse transcription or integration in MEC, HIV
p24 release, and the use of a sensitive GFP reporter virus. This
discrepancy may be due in part to the techniques used to
isolate pure populations of MEC and to the use of different
isolates of HIV-1. In the present study, we adapted protocols
FIG. 4. MEC maintain close physical contact with CD4 T lymphocytes. (A) Transmission electron microscopy image showing junctions and
clefts between MEC and lymphocytes (L). (B) Enlarged image of boxed area, showing junctions between cells (black arrows). Junctions between
MEC and lymphocytes were observed in all samples from two individual subjects, with conditions tested in duplicate, irrespective of HIV-1
infection of lymphocytes. (C and D) Images of separate observations of lymphocyte engulfment by MEC from two individual subjects. Lymphocyte
endocytosis was not dependent on HIV-1 infection of lymphocytes.
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for MEC isolation to yield a highly purified population of cells
that was free of contaminating fibroblasts and CD45 leu-
kocytes. Direct infection of MEC was evaluated using pri-
mary HIV-1 isolates, including two patient isolates with
tropism for either CCR5 or CXCR4. By comparison, the
previous study of MEC relied on the use of a T-cell-adapted
strain of HIV-1 (HIV-1HTLV-IIIB) and a highly cytopatho-
genic isolate (HIV-1P1).
However, our findings of HIV-1 receptors and coreceptors
CD4, CXCR4, CCR5, and GalCer on MEC indicate that direct
infection of MEC cannot be ruled out. A previous HIV-1
infectivity study using primary human MEC also reported CD4
mRNA transcripts by use of PCR, as well as “faint” expression
of CD4 and GalCer on MEC membranes by use of a radio-
binding assay (40). While expression of CCR5 and CXCR4 was
not evaluated in the report by Toniolo et al., our findings are
consistent with studies of murine mammary cells, which have
been found to express CCR5 and CXCR4 (2). In addition, breast
cancer studies have demonstrated the presence of CXCR4 in
human mammary tissue by use of immunohistochemistry (31).
Our findings also confirmed the widespread expression of the
glycosphingolipid GalCer, suggesting that HIV-1 transcytosis
across MEC via this receptor may be possible. Previous studies
have demonstrated GalCer-dependent transcytosis of HIV-1
across human intestinal cell lines, initiated by GalCer binding
to the ELDKWA epitope of the HIV-1 envelope glycoprotein
gp41 (1).
Direct infection of MEC with HIV appears unnecessary for
these cells to actively contribute to the transmission of HIV to
target cells trafficking through the mammary epithelial layer on
their way into the breast milk. Our EM results demonstrate the
presence of intact HIV-1 virions within endosomal compart-
ments in primary human MEC, suggesting that these cells are
capable of active uptake and intracellular sequestration of viri-
ons. Presumably, virus harbored within MEC may be targeted
for degradation; however, our coculture results suggest that
infectious virus may also be released extracellularly as free
virus or across cell-cell junctions toward proximal target cells.
Vesicular transcytosis of HIV-1 across tightly polarized intes-
tinal and endometrial epithelial cell layers has previously been
demonstrated during investigations of HIV-1 passage through
a mucosal layer (6, 17). In a nonepithelial cell model, dendritic
cells (DC) have been shown to capture infectious HIV-1 viri-
ons and subsequently transmit them to T cells via exocytosis,
FIG. 5. Activated CD4 T lymphocytes are productively infected
with HIV-1 after coculture with HIV-exposed MEC. Mean p24 antigen
concentrations in culture supernatants up to 14 days after coculture of
activated versus resting CD4 T lymphocytes with HIV-exposed and
washed MEC. Each experiment was conducted in triplicate wells. Data
represent the means  standard deviations (SD) from three individual
subjects.
FIG. 6. MEC secretions from the apical surface increase HIV-1
replication and cellular proliferation in infected PBMCs. (A) HIV-1-
infected PBMCs were cultured in MEC conditioned medium and com-
pared to controls cultured in medium alone. Mean HIV p24 antigen
concentrations on day 7 of the culture (*, P  0.02). Each experiment
was conducted in triplicate wells. Data represent mean values  SD
from two subjects. (B) Mean proliferation of HIV-1-infected PBMCs,
measured by a 3-(4,5 dimethylthiazol-2-yl)-5-(3-carboxymethoxyphe-
nyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS)-based assay
(*, P  0.0001). Data represent mean values  SD from the same two
subjects represented in panel A. (C) Cytokines, chemokines, and
growth factors (10 pg/ml) measured in MEC apical-surface condi-
tioned medium. Data represent the mean values  SD from four
subjects. IL-1ra, IL-1 receptor antagonist; G-CSF, granulocyte colony-
stimulating factor; IFN-g, gamma interferon; MCP-1, monocyte che-
moattractant protein 1; PDGF, platelet-derived growth factor.
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further supporting the concept of viral transfer to target cells
without de novo infection (45).
Our observations by EM also suggest that transcytosis
of lymphocytes across MEC may occur by direct migration
of lymphocytes through the MEC. In the rat mammary
model, lymphocytes have been observed to traverse through
intraepithelial gaps between MEC into the ductal lumen (33).
However, this phenomenon has not been observed directly in
human tissue, despite observations of T lymphocytes in close
proximity to the mammary epithelial layer (32).
To determine whether MEC can effectively capture and
transfer HIV-1, we performed coculture experiments using
MEC previously exposed to the virus. After extensive washes
(and in some cases trypsinization) to remove unbound virus,
MEC were cocultured with both activated and resting CD4
target cells. These conditions resulted in robust infection of the
virus in activated CD4 cells, confirming that HIV-1 captured
by MEC remains infectious and can initiate a productive in-
fection in susceptible target cells. In the absence of evidence
supporting direct infection of MEC by HIV-1, these data sug-
gest that MEC may internalize the virus and subsequently
release infectious virions.
Our study findings also suggest that while MEC do not
activate or lead to productive infection of quiescent T cells,
they may enhance their survival. One interpretation of these
findings is that T cells latently infected with HIV homing to the
mammary gland are not activated but rather are viably sus-
tained by MEC. Unlike in the rodent mammary gland, leuko-
cytes begin to accumulate in the lumen of human mammary
ducts prior to parturition (at least by week 34 of gestation)
(32). Since low levels of cell-to-cell transmission of HIV-1
occur among latently infected T cells in order to maintain an
infected-cell reservoir (37), it is possible that cell-to-cell HIV-1
transmission among both activated and resting T cells could
occur in the mammary gland during the formation of the cell-
rich colostrum. Therefore, physiologically relevant opportuni-
ties for HIV infection of activated target cells and for accumu-
lation of latently infected cells in the mammary gland may exist
in vivo.
Results from this study indicate an important effect of MEC
secretions on HIV-1 infection and replication in susceptible
target cells. As mentioned previously, MEC secretions may
also contribute to sustaining the viability of CD4 resting cells.
In an effort to better understand the environment created by
MEC in culture, we sought to characterize the soluble factors
released by MEC. Analysis of the apical secretions from the
polarized cells by multiplex assays revealed the presence of a
complex array of cytokines, chemokines, and growth factors.
Breast milk is known to contain many chemokines and cy-
tokines (24, 41), some of which may influence HIV-1 infec-
tion and transmission (7, 12, 20). Epidemiologic studies
have sought to find correlations between individual breast milk
components and transmission of HIV-1 through breast-feeding
or between HIV-infected and noninfected women (8, 35, 42,
44). However, a clear relationship has not been established,
making it likely that multiple components interact to affect cell
activation and virus replication within the breast milk milieu.
In summary, findings from this study demonstrate that MEC
play an active role in uptake of HIV-1 and can facilitate CD4
target cell infection, HIV replication, cell proliferation, and
survival of resting CD4 T cells. These results highlight the
complexity and importance of MEC and their potential con-
tribution to sustaining cell-free and cell-associated HIV-1 in
breast milk. Epidemiologic studies of breast milk from HIV-
infected, lactating women on HAART have demonstrated lit-
tle or no impact on cell-associated HIV proviral DNA, com-
pared to a rapid reduction in cell-free HIV RNA (23, 36). Our
findings support the concept proposed by these and other
studies which suggests that mammary tissue may represent a
distinct site of virus replication that is refractory to antiretro-
viral (ARV) intervention. Further studies are needed to deter-
mine whether mammary tissue harbors HIV-1 in vivo and
whether this site forms a reservoir for virus replication and
persistence within the host.
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